ATHIRA PHARMA
Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach and positively impact everyone.
ATHIRA PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.athira.com
Total Employee:
11+
Status:
Active
Contact:
(206) 221-8112
Email Addresses:
[email protected]
Total Funding:
233.6 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Google Universal Analytics Microsoft Exchange Online Office 365 Mail YouTube Sectigo SSL Sectigo Domain SSL Pound Sterling Japanese Yen
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - Athira Pharma
Primer Capital
Primer Capital investment in Convertible Note - Athira Pharma
Avidity Partners
Avidity Partners investment in Series B - Athira Pharma
Viking Global Investors
Viking Global Investors investment in Series B - Athira Pharma
Highline Capital Management
Highline Capital Management investment in Series B - Athira Pharma
Franklin Templeton Investments
Franklin Templeton Investments investment in Series B - Athira Pharma
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Athira Pharma
Rick Kayne
Rick Kayne investment in Series B - Athira Pharma
Suzanne Kayne
Suzanne Kayne investment in Series B - Athira Pharma
Ditch Plains Capital Management LP
Ditch Plains Capital Management LP investment in Series B - Athira Pharma
Key Employee Changes
Official Site Inspections
http://www.athira.com
- Host name: 45.60.98.212
- IP address: 45.60.98.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
